Bariatric surgery for diabetic comorbidities: A focus on hepatic, cardiac and renal fibrosis
Authors:
Open Access
- 21 October 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 1016635
Abstract
Graphical Pharmacological treatment and mechanisms of bariatric surgery for diabetic comorbidities.Keywords
Funding Information
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
This publication has 154 references indexed in Scilit:
- Myocardial Oxygen Consumption Change Predicts Left Ventricular Relaxation Improvement in Obese Humans After Weight LossObesity, 2011
- Weight-Independent Changes in Blood Glucose Homeostasis After Gastric Bypass or Vertical Sleeve Gastrectomy in RatsGastroenterology, 2011
- Integrated Regulation of Hepatic Metabolism by Fibroblast Growth Factor 21 (FGF21) in VivoEndocrinology, 2011
- Diet and Gastrointestinal Bypass–Induced Weight LossDiabetes, 2011
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and diseaseCell and tissue research, 2010
- Pro-Inflammatory CD11c+CD206+ Adipose Tissue Macrophages Are Associated With Insulin Resistance in Human ObesityDiabetes, 2010
- Urinary Albumin Excretion, HMW Adiponectin, and Insulin Sensitivity in Type 2 Diabetic Patients Undergoing Bariatric SurgeryObesity Surgery, 2009
- Common and unique mechanisms regulate fibrosis in various fibroproliferative diseasesJournal of Clinical Investigation, 2007
- Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)Kidney International, 2003